Advanced Strategies and Innovative Theragenerative Nano/Micro Biomaterials for Bone Cancer Therapy and Bone Tissue Regeneration with a Focus on Osteosarcoma Management.
1/5 보강
Osteosarcoma (OS), a highly malignant primary bone tumor, is a relatively rare cancer with an incidence of about 3.4 cases per million people annually, yet it remains the most common malignant bone tu
APA
Arfaoui J, Ghorbel A, et al. (2026). Advanced Strategies and Innovative Theragenerative Nano/Micro Biomaterials for Bone Cancer Therapy and Bone Tissue Regeneration with a Focus on Osteosarcoma Management.. ACS biomaterials science & engineering, 12(3), 1334-1372. https://doi.org/10.1021/acsbiomaterials.5c00795
MLA
Arfaoui J, et al.. "Advanced Strategies and Innovative Theragenerative Nano/Micro Biomaterials for Bone Cancer Therapy and Bone Tissue Regeneration with a Focus on Osteosarcoma Management.." ACS biomaterials science & engineering, vol. 12, no. 3, 2026, pp. 1334-1372.
PMID
41611648 ↗
Abstract 한글 요약
Osteosarcoma (OS), a highly malignant primary bone tumor, is a relatively rare cancer with an incidence of about 3.4 cases per million people annually, yet it remains the most common malignant bone tumor in children and adolescents. Current clinical treatments often fail to completely eradicate the tumor, resulting in recurrence and substantial bone loss. To address these challenges, advanced macro-, micro-, and nanoscale bioactive materials are increasingly needed in bone tumor management. These materials must not only replace lost tissue and integrate with host bone but also provide a supportive environment for osteoblast growth and healing. Biomaterial-mediated bone regeneration focuses on designing temporary scaffolds and injectable micro/nanosponges or gels that fill bone defects and replicate the native bone niche. Additionally, such biomaterials should offer therapeutic functions to eliminate residual cancer cells after resection. Enhancing the therapeutic index and treatment efficiency while simultaneously addressing bone loss is necessary for improving clinical outcomes in osteosarcoma management. This review highlights the most advanced strategies and innovative theragenerative nano- and microparticles containing biomaterials investigated for bone cancer management (killing bone tumor cells and/or repairing bone defects) focusing on osteosarcoma.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.